Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis

[1]  Arthur S Slutsky,et al.  High-frequency oscillation in early acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[2]  Sangeeta Mehta,et al.  Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. , 2012, JAMA.

[3]  D. Cook,et al.  Physicians Declining Patient Enrolment Into Clinical Trials: Incidence And Insights , 2012, ATS 2012.

[4]  M. Meade,et al.  Risk Factors For Pulmonary Embolism In Medical-Surgical ICU Patients , 2012, ATS 2012.

[5]  G. Guyatt,et al.  Dalteparin versus unfractionated heparin in critically ill patients. , 2011, The New England journal of medicine.

[6]  G. Guyatt,et al.  PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan. , 2011, Journal of critical care.

[7]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[8]  J. Foley.  Redressing the Balance , 2009, Science Signaling.

[9]  Ian Harvey,et al.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. , 2009, Journal of clinical epidemiology.

[10]  R. Bellomo,et al.  Screening and Study Enrolment in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) Replacement Therapy Trial , 2009, Blood Purification.

[11]  G. Guyatt,et al.  Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. , 2008, Archives of internal medicine.

[12]  G. Guyatt,et al.  Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors , 2008, Critical care.

[13]  D. Annane,et al.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial , 2007, The Lancet.

[14]  D. Cooper,et al.  Thromboprophylaxis for intensive care patients in Australia and New Zealand: a brief survey report. , 2005, Journal of critical care.

[15]  G. Guyatt,et al.  Burden of illness in venous thromboembolism in critical care: a multicenter observational study. , 2005, Journal of critical care.

[16]  G. Guyatt,et al.  Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. , 2005, Journal of critical care.

[17]  G. Guyatt,et al.  Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors , 2005, Critical care medicine.

[18]  A. Oxman,et al.  Systematic review to determine whether participation in a trial influences outcome , 2005, BMJ : British Medical Journal.

[19]  G. Guyatt,et al.  PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT): A Pilot Study. , 2004 .

[20]  Satoshi Morita,et al.  Physicians' reasons for not entering their patients in a randomized controlled trial in Japan. , 2004, The Tohoku journal of experimental medicine.

[21]  G. Guyatt,et al.  Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists , 2004, Critical care.

[22]  G. Guyatt,et al.  Burden of Illness in ThromboEmbolism in Critical Care (BITEC) study: a multicenter Canadian study , 2004, Critical Care.

[23]  D. Cook,et al.  Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. , 2003, Journal of critical care.

[24]  D. Cook,et al.  Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study. , 2001, Journal of critical care.

[25]  D. Cook,et al.  Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey , 2001, Critical care.

[26]  Vivek Goel,et al.  An Introduction to Multilevel Regression Models , 2001, Canadian journal of public health = Revue canadienne de sante publique.

[27]  R. Prescott,et al.  Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.

[28]  J. Hutson,et al.  Testicular and paratesticular tumours in children: 30 years' experience. , 1999, The Australian and New Zealand journal of surgery.

[29]  R. Simes,et al.  Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists. , 1999, The Australian and New Zealand journal of surgery.

[30]  V. Vavassori,et al.  Postoperative radiation therapy for adult soft tissue sarcomas: a retrospective study. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  A. Coates,et al.  Special article: Redressing the balance - The ethics of not entering an eligible patient on a randomised clinical trial Point of view , 1992 .

[32]  A. Coates,et al.  Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  C L Soskolne,et al.  Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. , 1984, The New England journal of medicine.